Document Detail

Two new compounds from Potentilla multicaulis Bunge.
MedLine Citation:
PMID:  23148512     Owner:  NLM     Status:  Publisher    
Two new compounds (triterpenoid saponin and heterocyclic compound), 2α,3β, 19α,23,30-pentahydroxyurs-12-en-28-oic acid-28-O-β-d-glucopyranosyl ester (1) and N-hydroxyl-hexahydroazepin-2,4-diones (2), with 11 known compounds, picein (3), (7S,8R)-dihydrodehydrodiconiferyl alcohol-9'-O-β-d-glucopyranoside (4), (+)-1-hydroxy-2-epipinoresinol-1-β-d-glucoside (5), (+)-1-hydroxypinoresinol-1-β-d-glucoside (6), (+)-1-hydroxypinoresinol-4'-β-d-glucoside (7), schaftside (6-C-β-d-glucopyranosyl-8-C-α-l-arabinosyl apigenin) (8), isoschaftside (6-C-α-l-arabinosyl-8-C-β-d-glucopyranosyl apigenin) (9), isorhamnetin-3-O-β-d-glucopyranoside (10), quercetin-3-O-β-glucuronide (11), 8-O-methylherbacetin-3-O-sophoroside (12) and kaempferol (13), were isolated from Potentilla multicaulis Bunge. The structure of the compounds was elucidated by chemical and spectral evidence.
Lingyun Jia; Jing Wang; Chongning Lv; Tanye Xu; Lihua He; Yan Dong; Jincai Lu
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Natural product research     Volume:  -     ISSN:  1478-6427     ISO Abbreviation:  Nat. Prod. Res.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101167924     Medline TA:  Nat Prod Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
a School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University , Box 79, Wenhua Road 103, Shenhe District , Shenyang , Liaoning Province , 110016 , PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of the second ion-binding site in the G domain of H-Ras.
Next Document:  Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): target...